Abstract

Studies will be continued whose goal is the development of concise and efficient synthetic routes to structurally novel antitumor substances. Our efforts will include the completion of streptolydiqin and tetronolide. Further work toward completion of FK-506, and finally reinitiation of efforts toward a concise preparation of the esperimicin/calichemicin aglycone.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA029108-16
Application #
2007315
Study Section
Medicinal Chemistry Study Section (MCHA)
Project Start
1980-12-01
Project End
1998-12-31
Budget Start
1997-01-01
Budget End
1997-12-31
Support Year
16
Fiscal Year
1997
Total Cost
Indirect Cost

  Institution

Name
University of Rochester
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
208469486
City
Rochester
State
NY
Country
United States
Zip Code
14627